High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$17.3M
$17,289,760
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
XENE
S
Xenon Pharmaceuticals Inc.
DiFabio Andrea
• Officer • Chief Legal Officer
Sell to CoverΔOwn -34.8%
2026-03-10
$156,702
|
||||||
| XENE |
Xenon Pharmaceuticals Inc.
|
Officer • Chief Legal Officer
Sell to CoverΔOwn -34.8%
|
2026-03-10 | $156,702 | S | Form 4 |
|
XENE
S
Xenon Pharmaceuticals Inc.
KENNEY CHRISTOPHER JOHN
• Officer • Chief Medical Officer
Sell to CoverΔOwn -37.0%
2026-03-10
$166,559
|
||||||
| XENE |
Xenon Pharmaceuticals Inc.
|
Officer • Chief Medical Officer
Sell to CoverΔOwn -37.0%
|
2026-03-10 | $166,559 | S | Form 4 |
| XENE |
Xenon Pharmaceuticals Inc.
|
CEO
Sell to CoverΔOwn -43.3%
|
2026-03-10 | $677,357 | S | Form 4 |
| XENE |
Xenon Pharmaceuticals Inc.
|
CEO
Other
|
2026-03-09 | $1,819,850Largex4 | M | Form 4 |
|
XENE
S
Xenon Pharmaceuticals Inc.
MORTIMER IAN
• CEO
10b5-1 SellΔOwn -26.9%
2026-03-09
$16,289,143MEGAx9
|
||||||
| XENE |
Xenon Pharmaceuticals Inc.
|
CEO
10b5-1 SellΔOwn -26.9%
|
2026-03-09 | $16,289,143MEGAx9 | S | Form 4 |